Sleep Initiation and Maintenance Disorders Completed Phase 2 Trials for Vestipitant (DB11949)

IndicationStatusPhase
DBCOND0029149 (Sleep Initiation and Maintenance Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00606697A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary InsomniaTreatment